[1]
S. Haque, A. Shukla, and A. Kem, “Treatment satisfaction and safety of sitagliptin versus pioglitazone in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy”, Int J Basic Clin Pharmacol, vol. 6, no. 2, pp. 338–343, Jan. 2017.